Monthly
Flexibility with month-to-month billing.
- Compounded Semax therapy
- Licensed clinician oversight
- Care-team messaging
- Free discreet shipping
Semax is a nootropic peptide studied for its potential to support cognitive function, focus, and mental clarity. Truvera’s Semax Cognitive Therapy offers a physician-guided approach for individuals seeking enhanced productivity and neurological support.
Potential Benefits
Short Version
Physician-guided nootropic peptide therapy designed to enhance focus and cognitive performance.
Neuropeptide · Cognitive Therapy
Semax is a synthetic heptapeptide analog of ACTH(4-7), engineered to promote BDNF production and neuroprotection without adrenal stimulation. Prescribed by a licensed clinician, compounded to order, and shipped to your door.
How it works
From online intake to medication delivered — in as little as 3 days.
A 5-minute medical intake covers your health history, current cognitive symptoms, medications, and cognitive performance goals. No appointment needed.
A licensed US clinician reviews your intake and, if clinically appropriate, issues your Semax prescription and compounding order.
Your Semax is compounded at a licensed US pharmacy and shipped in discreet, temperature-controlled packaging.
Message your care team anytime. We monitor your cognitive response and adjust your protocol at every check-in.
Pricing
One monthly price covers your clinician visits, compounded medication, shipping, and care team access.
Flexibility with month-to-month billing.
Save 17% vs monthly
Best balance of savings and commitment.
Save 28% vs monthly
Our best price for long-term cognitive support.
Semax is a compounded neuropeptide, not an FDA-approved drug in the United States. Prescriptions are issued only at the discretion of licensed clinicians and only when medically appropriate.
Eligibility
What is Semax?
Semax is a synthetic heptapeptide analog of ACTH(4-7) — the behaviorally active fragment of adrenocorticotropic hormone — developed in the 1980s at Russia's Institute of Molecular Genetics under the direction of academician Nikolai Myasoedov. The original goal was to preserve the nootropic and neuroprotective properties of ACTH while eliminating its adrenal and steroidogenic effects. By isolating and extending the ACTH(4-7) core sequence with a Pro-Gly-Pro C-terminal addition, researchers created a molecule that engages central nervous system targets without activating the hypothalamic-pituitary-adrenal axis.
Semax's most studied mechanism is upregulation of brain-derived neurotrophic factor (BDNF) and its receptor TrkB, along with broader neurotrophin signaling including nerve growth factor (NGF). BDNF is central to synaptic plasticity, long-term potentiation, and neuronal survival — making its upregulation a key target for cognitive enhancement and neuroprotection. Semax also modulates dopaminergic and serotonergic transmission, contributing to improvements in attention, motivation, and mood tone observed in clinical use. In ischemia models, Semax has demonstrated robust neuroprotective effects by reducing neuronal apoptosis and inflammatory cytokine expression following hypoxic injury — the mechanistic basis for its approved use in Russia for stroke and transient ischemic attack.
In Russia, Semax holds regulatory approval and is used clinically for stroke recovery, cognitive impairment, and optic nerve disease. It is not approved by the FDA in the United States, but is available through licensed 503A compounding pharmacies with a valid prescription. Intranasal administration is the standard route: nasal mucosa allows direct peptide transport along olfactory nerve pathways into the CNS, bypassing first-pass hepatic metabolism and achieving rapid central bioavailability. TruVera's Semax is compounded to order at licensed US pharmacies and dispensed only following clinician review and prescription.
Patient experience
"I've struggled with focus my entire adult life and was skeptical about peptides. Three weeks into Semax I noticed I could hold a train of thought through a full work block — something that used to take serious effort. The intake was fast and my clinician was thorough about explaining what to expect."
"The mental clarity I get from Semax is unlike anything I've tried before. Brain fog that I'd accepted as baseline just lifted. My memory for details at work is noticeably sharper and I feel less mentally drained at the end of the day."
"I started Semax to recover cognitively after a period of burnout. The difference in my ability to process information quickly and retain what I read has been significant. TruVera's care team checked in regularly and adjusted my protocol when I had questions."
FAQ
Semax is a synthetic heptapeptide analog of ACTH(4-7), engineered to deliver the nootropic and neuroprotective effects of adrenocorticotropic hormone without adrenal stimulation. It was developed at Russia's Institute of Molecular Genetics and holds regulatory approval in Russia for use in stroke, transient ischemic attack, and cognitive impairment. It is not FDA-approved in the United States. TruVera provides Semax through licensed compounding pharmacies under Section 503A of the Federal Food, Drug, and Cosmetic Act — available only with a valid prescription from a licensed US clinician.
Patients and clinical users commonly report improvements in sustained attention, working memory, information processing speed, and mental stamina. Semax's upregulation of BDNF supports synaptic plasticity and long-term memory consolidation, while its dopaminergic and serotonergic modulation contributes to improved motivation and mood tone. Neuroprotective effects may also help maintain cognitive function under stress or following neurological insult. Individual responses vary; a clinician will evaluate your specific goals and baseline before prescribing.
Semax is administered intranasally — typically as drops applied to the nasal mucosa 2–3 times daily. This route allows the peptide to travel along olfactory nerve pathways directly into the central nervous system, bypassing the liver and achieving rapid CNS uptake. Your clinician will specify your exact dose, concentration, and dosing schedule based on your intake and cognitive goals.
Some patients report increased mental clarity and focus within 1–2 weeks of starting Semax; more substantial cognitive improvements — including enhanced memory and reduced brain fog — are typically observed after 3–4 weeks of consistent use. Neuroprotective and neuroplasticity-related benefits tend to accumulate over longer treatment periods. Your clinician will assess your progress at regular check-ins and adjust the protocol as needed.
Semax is generally well tolerated. The most commonly reported effects are mild nasal irritation or transient discomfort at the site of intranasal administration. Some users report mild fatigue during the first few days as the body adjusts. At higher doses, anxiety or heightened arousal has been noted in some individuals — a reason why clinician oversight and appropriate dosing are important. Long-term safety data from large-scale human trials in the US is limited. Your clinician will review your full health history, medications, and any potential interactions before issuing a prescription.
Yes. You can pause or cancel at any time through your TruVera patient portal — no phone calls, no cancellation fees. If you have questions about your protocol or want to discuss adjusting your dose before canceling, your care team is always available to help.